First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01

Toshio Shimizu, Jacob Sands, Kiyotaka Yoh, +14

Journal of Clinical Oncology

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study

Aditya Bardia, Ian E. Krop, Takahiro Kogawa, +17

Journal of Clinical Oncology

Criterion validity of the visual estimation method for determining patients' meal intake in a community hospital

Yui Kawasaki, Masashi Sakai, Kazuhiro Nishimura, +4

Clinical Nutrition

Food ChoiceNutritionBody CompositionCriterion ValidityHealth Sciences +10

Abstract GS1-05: Datopotamab deruxtecan in advanced/metastatic HER2- breast cancer: Results from the phase 1 TROPION-PanTumor01 study

Ian E. Krop, Dejan Juric, Toshio Shimizu, +16

Cancer Research

Breast OncologyImmunologyPathologyImmunotherapeuticsMetronomic Chemotherapy +19

OA03.03 Datopotamab Deruxtecan (Dato-DXd; DS-1062), a TROP2 ADC, in Patients With Advanced NSCLC: Updated Results of TROPION-PanTumor01 Phase 1 Study

Alexander I. Spira, Aaron Lisberg, Jacob Sands, +14

Journal of Thoracic Oncology

Advanced NsclcMedicineOa03.03 Datopotamab DeruxtecanPathologyImmune Checkpoint Inhibitor +5

LBA49 Efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC) and actionable genomic alterations (AGAs): Preliminary results from the phase I TROPION-PanTumor01 study

Edward B. Garon, Melissa L. Johnson, Aaron Lisberg, +13

Annals of Oncology

Lba49 EfficacyActionable Genomic AlterationsMedicinePathologyPreliminary Results +7

TROPION-PanTumor01: Dose analysis of the TROP2-directed antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd, DS-1062) for the treatment (Tx) of advanced or metastatic non-small cell lung cancer (NSCLC).

Funda Meric‐Bernstam, Alexander I. Spira, Aaron Lisberg, +15

Journal of Clinical Oncology

PathologyTrop2-directed Antibody-drug ConjugateImmunotherapeuticsPharmacotherapyMetronomic Chemotherapy +19

Is mindful eating sustainable and healthy? A focus on nutritional intake, food consumption, and plant-based dietary patterns among lean and normal-weight female university students in Japan

Yui Kawasaki, Rie Akamatsu, Yoko Fujiwara, +6

Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity

NutritionBehavioral SciencesWellness StudiesNutritional IntakeHealth Promotion +7

MA03.02 TROPION-PanTumor01: Updated Results From the NSCLC Cohort of the Phase 1 Study of Datopotamab Deruxtecan in Solid Tumors

Edward B. Garon, Melissa L. Johnson, Aaron Lisberg, +12

Journal of Thoracic Oncology

Tumor BiologyEndocrine OncologyTumoral PathologyMedicinePathology +7

Abstract P6-10-03: Datopotamab Deruxtecan (Dato-DXd) in Advanced Triple-Negative Breast Cancer (TNBC): Updated Results From the Phase 1 TROPION-PanTumor01 Study

Aditya Bardia, Ian E. Krop, Funda Meric‐Bernstam, +14

Cancer Research

Breast OncologyImmunologyImmunoeditingPathologyImmunotherapeutics +18